36P The association between tri-nucleotide-repeat containing 9 (TNRC9) /LOC643714 genetic variations and breast cancer in Egyptian females

Abstract

Conclusions: Cytotoxic CD4 T cell is an emerging prognostic biomarker within the breast cancer immune environment. Further dissection of CD4 CTL activity could carry a predictive signal for immunotherapy in patients with breast cancer.Legal entity responsible for the study: The authors.